|
⚲
|
| Keyboard |
| Harris Geoffrey E
✚
|
|
|---|---|
| CIK # | 0001611395 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001611395] | |
| 4 | [0001611395] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Harris Geoffrey E | |
| Cancer Genetics Inc | |
| Telemynd Inc | |
| CNS Response Inc | |
| American CareSource Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2023-01-17 | Grant | 5,712 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-11-18 | Sell | 666 | $1.33 | 886 |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-11-18 | Sell | 99 | $1.34 | 133 |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-10-17 | Grant | 10,841 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-07-18 | Grant | 6,141 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-04-18 | Grant | 5,157 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-03-30 | Grant | 43,478 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-01-18 | Grant | 4,055 | $1.31 | 5,312 |
|
Cancer Genetics Inc VYNT
Stock option (right to buy) · derivative
|
2021-03-30 | Grant | 13,015 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2019-07-23 | Grant | 100,000 | $0.00 | |
|
Telemynd Inc NONE
Common Stock
|
2019-07-16 | Other | 97,110 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2019-01-14 | Buy | 100,000 | $0.23 | 23,000 |
|
CNS Response Inc MYND
COMMON STOCK
|
2018-10-08 | Grant | 45,000 | $1.38 | 62,100 |
|
CNS Response Inc MYND
Common Stock
|
2017-12-06 | Buy | 3,500 | $3.80 | 13,300 |
|
CNS Response Inc MYND
Common Stock
|
2017-12-06 | Buy | 1,000 | $3.85 | 3,850 |
|
CNS Response Inc MYND
Common Stock
|
2017-12-05 | Buy | 52 | $3.60 | 187 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-09-28 | Grant | 2,500 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-09-28 | Grant | 5,000 | $0.00 | |
|
CNS Response Inc MYND
Common Stock
|
2017-09-19 | Grant | 18,000 | $0.00 | |
|
CNS Response Inc MYND
Director Stock Option (right to buy) · derivative
|
2017-09-19 | Grant | 18,000 | $0.00 | |
| showing 20 of 42 most recent transactions | |||||